home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Pain Therapeutics Summit

 
  June 14, 2012  
     
 
Arrowhead Publishers and Conferences, San Francisco, CA
October 3-4, 2012


ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.

This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.
 
 
Organized by: Arrowhead Publishers and Conferences
Invited Speakers:

Allan Basbaum, Ph.D., Professor & Chair, Department of Anatomy, University of California, San Francisco

Mark T. Brown, MD, Executive Director, Clinical Program Leader for Osteoarthritis and Cancer Pain Studies, Pfizer Inc.

Jun X. Chen, Ph.D., Principal Research Scientist GPRD, Neuroscience, Abbott Laboratories

Peter French, Ph.D., Chief Executive Officer, Benitec Biopharma

Michael LaCroix-Fralish, Ph.D., Staff Scientist, Pain Therapeutics Group, Regeneron Pharmaceuticals

Nancy E. Lane, M.D., Endowed Professor of Medicine and Rheumatology, Director, Musculoskeletal Diseases of Aging Research Group Director, Academic Geriatric Resource Program, Co-Director, Building Interdisciplinary Research Careers in Women's Health (BIRCWH), Co-Director, Center for Translational Research in Osteoarthritis, UC Davis Health System

Sean Mackey, MD, Ph.D., Chief, Division of Pain Management, Stanford University School of Medicine, Associate Professor of Anesthesiology, Director, Stanford Systems Neuroscience & Pain Lab

Robert Medve, MD, Vice President & Chief Medical Officer, Nektar Therapeutics

Brian Meltzer, MD, Executive Director, R&D Innovation, Purdue Pharma

Magdalene Moran, Ph.D., Vice President, Biology, Hydra Biosciences

Markus Muttenthaler, Ph.D., Departments of Chemistry and Cell Biology, The Scripps Research Institute

Daniela Salvemini, Ph.D., Professor, Saint Louis University School of Medicine

(Chair) William K. Schmidt, Ph.D., President, NorthStar Consulting, LLC, VP Clinical & Regulatory, Arcion Therapeutics, VP Clinical Development, CrystalGenomics (CG Pharmaceuticals)

Neil Singla, MD, Founder & Chief Scientific Officer, Lotus Clinical Research, LLC

Tony L. Yaksh, Ph.D., Professor and Vice Chair for Research, Department of Anesthesiology and Professor of Pharmacology,University of California, San Diego

 
Deadline for Abstracts: TBA
 
Registration: online
E-mail: john.waslif@arrowheadpublishers.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.